Formula Growth’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $490K | Buy |
+215,000
| New | +$682K | 0.22% | 118 |
|
|
2024
Q4 | – | Sell |
-186,926
| Closed | -$5.29M | – | 123 |
|
|
2024
Q3 | $5.29M | Buy |
186,926
+15,375
| +9% | +$396K | 1.82% | 10 |
|
|
2024
Q2 | $3.28M | Sell |
171,551
-76,400
| -31% | -$1.95M | 1.19% | 27 |
|
|
2024
Q1 | $8.13M | Sell |
247,951
-5,050
| -2% | -$161K | 2.6% | 2 |
|
|
2023
Q4 | $8.36M | Sell |
253,001
-43,900
| -15% | -$1.24M | 2.68% | 2 |
|
|
2023
Q3 | $8.08M | Sell |
296,901
-2,609
| -0.9% | -$72.5K | 2.76% | 2 |
|
|
2023
Q2 | $9.08M | Buy |
299,510
+6,590
| +2% | +$213K | 2.89% | 1 |
|
|
2023
Q1 | $9.51M | Sell |
292,920
-37,900
| -11% | -$1.2M | 3.06% | 1 |
|
|
2022
Q4 | $9.29M | Buy |
330,820
+69,700
| +27% | +$2M | 2.63% | 2 |
|
|
2022
Q3 | $9.38M | Sell |
261,120
-69,200
| -21% | -$2.44M | 2.68% | 3 |
|
|
2022
Q2 | $10.1M | Buy |
330,320
+26,000
| +9% | +$758K | 2.81% | 1 |
|
|
2022
Q1 | $9.83M | Sell |
304,320
-26,580
| -8% | -$696K | 1.85% | 10 |
|
|
2021
Q4 | $9.16M | Sell |
330,900
-159,125
| -32% | -$4.56M | 1.63% | 16 |
|
|
2021
Q3 | $15.2M | Hold |
490,025
| – | – | 2.17% | 9 |
|
|
2021
Q2 | $10.3M | Buy |
490,025
+195,000
| +66% | +$3.91M | 1.43% | 18 |
|
|
2021
Q1 | $5.96M | Buy |
295,025
+160,000
| +118% | +$3.04M | 0.86% | 32 |
|
|
2020
Q4 | $2.16M | Hold |
135,025
| – | – | 0.36% | 78 |
|
|
2020
Q3 | $1.68M | Sell |
135,025
-1,468,905
| -92% | -$17.3M | 0.31% | 92 |
|
|
2020
Q2 | $11.4M | Sell |
1,603,930
-90,095
| -5% | -$603K | 1.93% | 13 |
|
|
2020
Q1 | $9.2M | Sell |
1,694,025
-214,000
| -11% | -$1.91M | 1.76% | 17 |
|
|
2019
Q4 | $17.3M | Buy |
1,908,025
+170,000
| +10% | +$1.38M | 2.18% | 11 |
|
|
2019
Q3 | $12.5M | Buy |
1,738,025
+680,000
| +64% | +$4.88M | 1.87% | 13 |
|
|
2019
Q2 | $8.41M | Buy |
1,058,025
+420,000
| +66% | +$4.97M | 1.2% | 28 |
|
|
2019
Q1 | $8.03M | Buy |
638,025
+514,000
| +414% | +$8.14M | 1.13% | 28 |
|
|
2018
Q4 | $2.47M | Hold |
124,025
| – | – | 0.41% | 52 |
|
|
2018
Q3 | $3.52M | Sell |
124,025
-892,882
| -88% | -$21.3M | 0.4% | 54 |
|
|
2018
Q2 | $21.4M | Sell |
1,016,907
-1,009,623
| -50% | -$19.1M | 2.34% | 12 |
|
|
2018
Q1 | $28.9M | Sell |
2,026,530
-17,170
| -0.8% | -$246K | 3.43% | 2 |
|
|
2017
Q4 | $25.1M | Buy |
2,043,700
+1,240,200
| +154% | +$17.5M | 3.3% | 5 |
|
|
2017
Q3 | $14.3M | Buy |
803,500
+703,000
| +700% | +$14.5M | 2.25% | 8 |
|
|
2017
Q2 | $2.55M | Buy |
100,500
+35,000
| +53% | +$842K | 0.44% | 61 |
|
|
2017
Q1 | $1.46M | Buy |
+65,500
| New | +$1.26M | 0.3% | 95 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Formula Growth's EVH Position: Q1 2026 in Review
Formula Growth opened a new position in Evolent Health (EVH) in Q1 2026: 215,000 shares worth $490K. The stake represents 0.22% of the portfolio and ranks #118 among its holdings. This is a return to the name: Formula Growth previously reported a position in EVH as recently as Q3 2024.
Formula Growth first reported a position in EVH in Q1 2017 and has held it in 32 quarters since. The position peaked at $28.9M in Q1 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Formula Growth held 215,000 shares of Evolent Health worth $490K as of Q1 2026.
- Evolent Health was a new Formula Growth position in Q1 2026.
- Evolent Health made up 0.22% of Formula Growth's portfolio in Q1 2026, its #118 holding.
- Formula Growth first reported a position in Evolent Health in Q1 2017 and has held it in 32 quarters since.
- Formula Growth's Evolent Health position peaked at $28.9M in Q1 2018.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.